Uni-Bio Science Group Income Statement

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	586.21	552.98	484.72	440.32	353.41
Revenue Growth (YoY)	6.01%	14.08%	10.08%	24.59%	69.27%
Cost of Revenue	98.65	91.91	91.9	105.43	76.4
Gross Profit	487.56	461.07	392.82	334.88	277.01
Selling, General & Admin	352.46	312.24	288.65	258.31	232.85
Research & Development	39.77	52.28	35.58	35.78	50.22
Other Operating Expenses	-2.91	-5.53	-12.29	-6.99	-5.16
Operating Expenses	390.33	359.17	311.93	287.64	281.84
Operating Income	97.23	101.9	80.88	47.24	-4.83
Interest Expense	-1.51	-1.19	-0.78	-0.38	-0.48
Interest & Investment Income	3.06	3.35	1.35	1.3	0.47
Earnings From Equity Investments	0.27	-	-	-	-
Other Non Operating Income (Expenses)	-1.91	-12.32	-4.94	-2.17	2.72
EBT Excluding Unusual Items	97.15	91.74	76.51	45.99	-2.12
Gain (Loss) on Sale of Investments	-	-	-	-	0.04
Gain (Loss) on Sale of Assets	-	-0.57	-0.61	-0.76	-2.63
Asset Writedown	-	-	-	-	0
Legal Settlements	-	-	-	-2.31	-15.61
Other Unusual Items	4.37	-	-	0.36	0.3
Pretax Income	101.52	91.17	75.9	43.29	-20.01
Income Tax Expense	8.19	8.4	5.02	4.78	-0.42
Net Income	93.33	82.77	70.88	38.51	-19.59
Net Income to Common	93.33	82.77	70.88	38.51	-19.59
Net Income Growth	12.75%	16.79%	84.04%	-	-
Shares Outstanding (Basic)	5,971	6,140	6,365	6,361	6,372
Shares Outstanding (Diluted)	5,971	6,140	6,365	6,361	6,372
Shares Change (YoY)	-2.75%	-3.53%	0.07%	-0.17%	-0.57%
EPS (Basic)	0.02	0.01	0.01	0.01	-0.00
EPS (Diluted)	0.02	0.01	0.01	0.01	-0.00
EPS Growth	15.73%	21.44%	83.35%	-	-
Free Cash Flow	-	28.71	39.11	20.23	3.61
Free Cash Flow Per Share	-	0.01	0.01	0.00	0.00
Dividend Per Share	0.003	0.003	-	-	-
Dividend Growth	13.00%	-	-	-	-
Gross Margin	83.17%	83.38%	81.04%	76.05%	78.38%
Operating Margin	16.59%	18.43%	16.69%	10.73%	-1.37%
Profit Margin	15.92%	14.97%	14.62%	8.75%	-5.54%
Free Cash Flow Margin	-	5.19%	8.07%	4.59%	1.02%
EBITDA	109.67	114.33	92.55	59.53	10.88
EBITDA Margin	18.71%	20.68%	19.09%	13.52%	3.08%
D&A For EBITDA	12.44	12.44	11.66	12.29	15.71
EBIT	97.23	101.9	80.88	47.24	-4.83
EBIT Margin	16.59%	18.43%	16.69%	10.73%	-1.37%
Effective Tax Rate	8.07%	9.21%	6.62%	11.03%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.